by Cort Johnson | Oct 13, 2018 | Cannabis, Cymbalta, Dextromethorphan, Fibromyalgia, Homepage, Low Dose Naltrexone, Lyrica, Neuroinflammation, Supplements
“Finding an objective neurochemical change in the brains of people who are used to being told that their problems are imaginary is pretty important…” Marco Loggia Jarred Younger has believed for quite some time that the glial cells in fibromyalgia... 
by Cort Johnson | Jun 12, 2018 | Cannabis, Coping, Cymbalta, Fibromyalgia, Fibromyalgia and Pain, Flexeril, Homepage, Lyrica, Mind/body, Opioid drugs
Daniel Clauw M.D. With 200 publications reaching back over twenty years Daniel Clauw is perhaps the most prolific fibromyalgia researcher of our time. He’s fought for many years to validate fibromyalgia as a real and serious illness. (For years the... 
by Cort Johnson | Jul 27, 2017 | Brain, Fibromyalgia and Pain, Homepage, Insula, Lyrica, Research
The “Global Pain” Diseases There are two kinds of “pain” in fibromyalgia. There’s a more ordinary kind of pain – the burning, stabbing, aching, etc. usually associated with some type of injury (even though no overt physical injuries... 
by Cort Johnson | Jul 8, 2017 | Fibromyalgia, Homepage, Low Dose Naltrexone, Lyrica, Propanolol, Treatment
It wasn’t supposed to go this way. Daiichi Sankyo bet big, big money that it’s safer, more effective version of Lyrica (pregabalin) called Mirogabalin was going to be the next big thing in fibromaylgia (FM). It was so confident that it embarked on a... 
by Cort Johnson | Apr 30, 2017 | Cymbalta, Fibromyalgia, Lyrica, Savella, Treatment
The current crop of FM drugs is hardly the cat’s meow but a recent study suggests that with FM drugs more might be better; i.e. combining drugs – perhaps in lower doses – might help both drugs to work better. Find out more in Combining Drugs May Work... 
by Cort Johnson | Oct 3, 2016 | Antivirals, Fibromyalgia, Flexeril, Lyrica, Treatment
Tomnya had everything going for it; a novel approach to pain and good Phase II trial results, but Tonix’s reformulation of Flexeril that was expected to help with both sleep and pain tanked in its critical Phase III trial. Check out what happened with it,...
